Alzheimer's & Dementia·YesterdayProteomic dysregulation associated with cerebral amyloid angiopathyStudy in peopleBiomarkersPaper
Circulation·6 OctLipid Burden and Efficacy of Preventive PCI of Vulnerable Atherosclerotic Coronary Plaques: Post Hoc Analysis From the PREVENT TrialTrial in peopleInterventionsPaper
Geospatial Health·5 OctGeospatial approaches to analysing spatial patterns of stroke incidence and mortality: a systematic reviewReviewPopulationsPaper
JACC Asia·28 SepPrognostic Impact of Lipoprotein(a) on Cardiovascular Outcomes Across Coronary Complexity in Patients Undergoing Coronary RevascularizationCohort study of 4,591 peopleLipoproteinPaper
Nutrients·28 SepMicrobiome-Derived Metabolic Signaling in the Gut-Skin Axis: Implications for Nutricosmetics and Healthy Skin AgingReviewShort-chain fatty acid metabolismPaper
Alzheimer's & Dementia·26 SepTranscriptional risk score for chronic kidney disease: relation to Alzheimer's diseaseCohort study of 665 peopleChronic kidney diseasePaper
Nature Communications·24 SepTirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetesCohort study in peopleGLP-1 receptor agonistsPaper
The Journal of Nutrition·22 SepDietary Patterns Are Key Predictors of Cardiovascular Risk Beyond Genetic Risk Across Metabolic Syndrome Trajectories in A Korean Prospective Cohort StudyCohort study of 58,701 peopleCardiovascular diseasePaper
JACC Case Reports·17 SepCardiovascular Outcomes With Sodium-Glucose Cotransporter 2 Inhibitors in Ethnically Diverse Patients With Heart FailureCohort study of 413 peopleSGLT2 inhibitorsPaper
Journal of Alzheimer's Disease·1 SepModel-based ordering of the ALPS index among Alzheimer's disease biomarkersStudy in peopleBiomarkersPaper
Knee Surgery, Sports Traumatology, Arthroscopy·10 AugAutologous adipose-derived mesenchymal stromal cell injection for knee osteoarthritis improves pain and function without a clear increase in adverse events: A systematic review and meta-analysis of randomized controlled trialsReviewInterventionsPaper
AAIC 2025 Abstract·11 JanCharacterizing early symptomatic AD patients by visual and quantitative tau profilesTrial in peoplePopulationsPaper
AAIC 2025 Abstract·10 JanTau PET and Plasma p ‐tau217 as Independent and Synergistic Predictors of Clinical Progression in Early Symptomatic AD Patients With Amyloid and Tau PathologyTrial in peopleBiomarkersPaper
AAIC 2025 Abstract·8 JanAssociation of Occipital Amyloid PET Burden with ARIA‐E: Exploratory Analyses in Three Clinical Trials of DonanemabTrial in peopleBiomarkersPaper
AAIC 2025 Abstract·26 DecKorean JOint RegistrY for ALZheimer's Treatment and Diagnostics (JOY‐ALZ): Establishing a Nationwide RWD Registry for Alzheimer's Disease in KoreaAI & dataPaper
AAIC 2025 Abstract·26 DecDevelopment of a digital GARD visual memory task to detect an early cognitive change in Alzheimer's diseaseStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecPharmacological characterization of DA‐7503: a novel tau aggregation inhibitor in clinical development for Alzheimer’s disease and primary tauopathiesExperiments in animalsInterventionsPaper
AAIC 2025 Abstract·25 DecBlood‐based transcriptional risk score for Parkinson's disease is associated with cognitive decline in Alzheimer's diseaseStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecAssociation of Occipital Amyloid PET Burden with ARIA‐E: Exploratory Analyses in Three Clinical Trials of DonanemabTrial in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecImpact of cognitive reserve markers on incident mild cognitive impairment and dementia: Evidence from the Korean Longitudinal Study of Aging, 2006‐2022Study in peoplePopulationsPaper